What is PD Labs?
PD Labs operates as a full-service compounding pharmacy, dedicated to creating a diverse range of highly specialized formulations. Their expertise spans critical areas including autism spectrum disorder treatments, advanced pain management solutions, and the development of various tablet formulas, alongside other therapeutic applications. The company's commitment to precision and tailored pharmaceutical solutions positions it as a key player in a niche but vital segment of the healthcare industry.
How much funding has PD Labs raised?
PD Labs has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for PD Labs?
The recent large-scale late-stage funding and major strategic investment signal a strong vote of confidence in PD Labs' business model and future growth potential. This influx of capital is expected to fuel further expansion, potentially enabling the company to scale its operations, enhance its research and development capabilities for new specialized formulations, and broaden its market reach. PD Labs is poised to leverage this financial backing to solidify its leadership in the compounding pharmacy space and address unmet patient needs with innovative pharmaceutical solutions.
See full PD Labs company page
